Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1995 Apr;3(2):139-54.
doi: 10.1007/BF02789110.

The biotechnology and applications of antibody engineering

R Rapley  1
Affiliations
Review

The biotechnology and applications of antibody engineering

R Rapley. Mol Biotechnol. 1995 Apr.

Abstract

The exquisite specificity of monoclonal antibodies (MAb) has long provided the potential for creating new reagents for the in vivo delivery of therapeutic drugs or toxins to defined cellular target sites or improved methods of diagnosis. However, many difficulties associated with their production, affinity, specificity, and use in vivo have largely confined their application to research or in vitro diagnostics. This situation is beginning to change with the recent developments in the applied molecular techniques that allow the engineering of the genes that encode antibodies rather than the manipulation of the intact antibodies themselves. Techniques, such as the polymerase chain reaction, have provided essential methods with which to generate and modify the genetic constituents of antibodies, allow their conjugation to toxins or drugs, provide ways of humanizing murine antibodies, and allow discrete modular antigen binding components to be produced. More recent developments of in vitro expression systems and powerful phage surface display technologies will without doubt play a major role in future antibody engineering and in the successful development of new diagnostic and therapeutic antibody-based reagents.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. N Engl J Med. 1990 Jul 19;323(3):173-8 - PubMed
    1. Nature. 1987 Aug 20-26;328(6132):731-4 - PubMed
    1. Bioessays. 1988 Oct;9(4):107-12 - PubMed
    1. Crit Rev Ther Drug Carrier Syst. 1993;10(1):1-28 - PubMed
    1. Biochemistry. 1990 Feb 13;29(6):1362-7 - PubMed

MeSH terms

LinkOut - more resources